Why Are People Filing Testosterone Lawsuits?
Thousands of men have filed testosterone lawsuits against manufacturers like AbbVie, Allergan, and Endo Pharmaceuticals because of harmful side effects. Lawsuit claims against testosterone replacement therapy (TRT) products – which are often prescribed to treat low testosterone levels (“Low-T”) in men – include an increased risk of blood clots, stroke, pulmonary embolism, heart disease, and prostate cancer, among other potentially deadly complications.Testosterone Dichloroacetate powder

The claims range from design defects and failure to warn about the potentially dangerous complications testosterone could cause, to negligence and breach of warranty, both express and implied. Other claims include false marketing efforts, such as marketing testosterone treatments for off-label uses not approved by the U.S. Food and Drug Administration (FDA). Specific claims were made in each individual lawsuit, as various people have experienced different problems with testosterone therapy.

Testosterone Products and Companies Being Sued

AndroGel testosterone lawsuits have been extremely high-profile, given the large number of cases filed against AbbVie Inc., a division of Abbott Laboratories. However, a number of other products and companies have also found themselves at the heart of legal claims. Companies like Endo Pharmaceuticals, GlaxoSmithKline, Actavis, and Eli Lilly and Company have all been named as defendants in these suits. Some of the TRT products under litigation are no longer available on the market.